Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer

Expertise

Prostate cancer

Andrology

Primære forskningsområder

Mainly company sponsored research.

  • Co-investigator “9785-MA-1002 PREMISE”. Observationsstudie på enzalutamide (Xtandi) behandling.
  • Co-investigator ”OX51-002”. Et randomiseret, placebo-kontrolleret forsøg til bestemmelse af dosis af tbl. Alfentanil, administreret under tungen, til lindring af smerter i forbindelse med udtagning af vævsprøver fra prostata, 2012.
  • Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study: PROSPER
  • Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study: PROSPECT
  • Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study - now OPEN LABEL extention study: PREVAIL
  • Co-investigator Phase II multicenter dobbelblinded randomized- now OPEN LABEL extention study: TERRAIN
  • Co-investigator Phase II multicenter open label study: 9785-CL-0321
  • Co-investigator Phase II multicenter dobbelblinded randomized study: CORAL
  • Publications:
    • “Pancreatitis acuta forårsaget af Ascaries lumbricoides” Ugeskr.Læger, 2000.
    • “Idiopathic partial thrombosis of the corpus cavernosum - etiology, diagnosis and treatment". Manuscript ID SJUN-2012-0078
    • ”Betydningen af testikulær microlithiasis”. Ugeskr Laeger 2014;176:V02130145
    • Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy: J Antimicrob Chemother, 2014
    • UFL-03-16-0184.R1 - Et almindeligt kondom kan anvendes til at fjerne fastsiddende metalringe omkring penis
  • Authorship:
    •  “Scrotums sygdomme”, Kirurgisk kompendium kittelbog, 3. udgave, 2011

Aktuel forskning

Several of the studies above is still running.

Low dose brachytherapy for localized prostate cancer: survival and toxicity results from a single center.

Mulige interessekonflikter

None

ID: 36817271